Imprint Wealth LLC Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Imprint Wealth LLC purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 9,111 shares of the pharmacy operator’s stock, valued at approximately $238,000.

Other institutional investors have also made changes to their positions in the company. Dark Forest Capital Management LP boosted its position in Walgreens Boots Alliance by 6.5% during the 3rd quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock valued at $654,000 after purchasing an additional 1,804 shares during the period. Deutsche Bank AG boosted its position in Walgreens Boots Alliance by 36.2% during the 3rd quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator’s stock worth $48,269,000 after acquiring an additional 576,534 shares during the period. Van ECK Associates Corp boosted its position in Walgreens Boots Alliance by 28.2% during the 3rd quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator’s stock worth $2,873,000 after acquiring an additional 28,400 shares during the period. Allspring Global Investments Holdings LLC boosted its position in Walgreens Boots Alliance by 3.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,444,686 shares of the pharmacy operator’s stock worth $32,130,000 after acquiring an additional 47,071 shares during the period. Finally, Vanguard Group Inc. boosted its position in Walgreens Boots Alliance by 14.5% during the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after acquiring an additional 10,962,030 shares during the period. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $17.64 on Wednesday. The business has a 50 day moving average price of $20.70 and a 200 day moving average price of $22.02. Walgreens Boots Alliance, Inc. has a twelve month low of $17.53 and a twelve month high of $36.14. The company has a market cap of $15.22 billion, a price-to-earnings ratio of -2.52, a PEG ratio of 1.09 and a beta of 0.73. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same quarter in the prior year, the company earned $1.16 EPS. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. Research analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Wall Street Analysts Forecast Growth

WBA has been the topic of a number of research reports. Bank of America dropped their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research note on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft dropped their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a research note on Wednesday, April 3rd. TheStreet raised Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. HSBC reaffirmed a “reduce” rating and set a $20.00 target price (down from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. Finally, Raymond James reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $24.36.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of the business’s stock in a transaction on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the transaction, the director now owns 3,000 shares in the company, valued at approximately $54,150. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, CFO Manmohan Mahajan acquired 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. In the last quarter, insiders bought 13,456 shares of company stock worth $270,423. 17.40% of the stock is currently owned by company insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.